Proprotein convertase subtilisin/kexin type 9: A new target molecule for gene therapy

Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as a novel target for controlling plasma levels of low-density lipoprotein cholesterol (LDL-C) and decreasing the risk of cardiovascular diseases. At present it is clear that the major classes of commonly prescribed lipid-lowering med...

Descripción completa

Detalles Bibliográficos
Autores principales: Banaszewska, Anna, Piechota, Michal, Plewa, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SP Versita 2012
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275701/
https://www.ncbi.nlm.nih.gov/pubmed/22311433
http://dx.doi.org/10.2478/s11658-012-0006-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275701/
https://www.ncbi.nlm.nih.gov/pubmed/22311433
http://dx.doi.org/10.2478/s11658-012-0006-7

Ejemplares similares